Implications of the reduction in prostate cancer screening using prostate-specific antigen

Curr Med Res Opin. 2022 Aug;38(8):1383. doi: 10.1080/03007995.2022.2061708. Epub 2022 May 27.

Authors

Alexandros A Tzovaras¹, Eleni Karatrasoglou², Sofia Talagani², Konstantina Perdikari², Christos Veros², Michail Nikolaou²

Affiliations

¹ First Medical Oncology Clinic, Saint-Savvas Cancer Hospital L. Alexandras 171, Athens 11522, Greece.
² First Medical Oncology Clinic, Saint-Savvas Cancer Hospital, Athens, Greece.

PMID: 35369834
DOI: 10.1080/03007995.2022.2061708

No abstract available

Publication types

Letter
Comment

MeSH terms

Early Detection of Cancer
Humans
Male
Mass Screening
Prostate-Specific Antigen*
Prostatic Neoplasms* / diagnosis

Substances

Prostate-Specific Antigen